Skip to main content

Table 2 Comparison of dry eye symptoms and ocular surface parameters in the Conventional surgery group before and after surgery

From: Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period

Parameters

baseline

1 month

3 month

p value

baseline vs

1 month

baseline vs

3 month

1 month vs

3 month

OSDIa

31.19 ± 7.28

33.43 ± 6.32

30.51 ± 6.65

0.003*

0.256

0.001#

EMASb

1.00 (1.00, 2.00)

1.00 (1.00, 2.00)

1.00 (1.00, 2.00)

0.109

0.334

0.763

MGYSSb

1.00 (1.00, 1.00)

1.00 (1.00, 2.00)

1.00 (1.00, 2.00)

0.088

0.002*

0.376

CFSb

0.00 (0.00, 1.00)

1.00 (0.50, 1.00)

0.00 (0.00, 1.00)

0.074

0.008*

0.564

TMHa/mm

0.18 ± 0.03

0.20 ± 0.02

0.20 ± 0.02

0.016*

0.020*

0.635

NITBUTa/s

5.52 ± 1.95

5.06 ± 1.54

4.99 ± 1.24

0.002*

0.035*

0.764

MGLSb

1.00 (1.00, 2.00)

1.00 (1.00, 1.50)

1.00 (1.00, 2.00)

0.564

0.655

0.157

  1. OSDI Ocular Surface Disease Index, MGYSS Meibomian gland yielding secretion score, CFS corneal fluorescein staining, TMH tear meniscus height, EMAS Eyelid margin abnormality score, MGLS meibomian gland loss score, TBUS tear film break-up time. a: Normal distribution data, the mean is expressed as Mean ± SD, and the paired sample t test is used for comparison between groups. b: Non-normally distributed data, the mean is represented by Median (P25, P75), and the comparison between groups is based on paired sample nonparametric Wilcoxon test. *p < 0.05 vs Baseline; #p < 0.05 vs 1 month